These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 25928287)

  • 1. Benefits and harms of mammography screening.
    Løberg M; Lousdal ML; Bretthauer M; Kalager M
    Breast Cancer Res; 2015 May; 17(1):63. PubMed ID: 25928287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits and harms of breast cancer screening: an independent review.
    Independent UK Panel on Breast Cancer Screening
    Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
    Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
    van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
    Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
    JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.
    Paci E; Broeders M; Hofvind S; Puliti D; Duffy SW;
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1159-63. PubMed ID: 24991022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography in women less than age 50 years.
    Kerlikowske K
    Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening.
    Mandrik O; Zielonke N; Meheus F; Severens JLH; Guha N; Herrero Acosta R; Murillo R
    Int J Cancer; 2019 Aug; 145(4):994-1006. PubMed ID: 30762235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits and harms of screening for cancer with a focus on breast screening.
    Brodersen J; Jørgensen KJ; Gøtzsche PC
    Pol Arch Med Wewn; 2010 Mar; 120(3):89-94. PubMed ID: 20332715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 47.